Keywords: novo, nordisk, sees, profits, rise, denmark, achieved
Novo Nordisk sees 4% profits rise for 2004
Article | 14 February 2005
Denmark's Novo Nordisk achieved net profits of 5.01 billion Danish kroner ($877.8 million) for 2004, a rise of 4.0%, with diluted earnings per share ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
